-
EP3423452
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3423452
| EP3423452 - WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 15.10.2024 Database last updated on 19.10.2024 | |
| Former | Examination is in progress Status updated on 26.06.2020 | ||
| Former | Request for examination was made Status updated on 07.12.2018 | ||
| Former | The international publication has been made Status updated on 08.09.2017 | Most recent event Tooltip | 15.10.2024 | New entry: Communication of intention to grant a patent | Applicant(s) | For all designated states University of Maryland, Baltimore 620 W. Lexington Street, 4th Floor Office of Research & Development Baltimore, MD 21201 / US | [2019/02] | Inventor(s) | 01 /
XUE, Fengtian 11900 Piney Glen Lane Potomac MD 20854 / US | 02 /
SHU, Yan 12043 Broad Meadow Lane Clarksville MD 21029 / US | [2019/02] | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [N/P] |
| Former [2019/02] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | Application number, filing date | 17760727.2 | 01.03.2017 | [2019/02] | WO2017US20224 | Priority number, date | US201662301863P | 01.03.2016 Original published format: US 201662301863 P | US201662301882P | 01.03.2016 Original published format: US 201662301882 P | US201662352634P | 21.06.2016 Original published format: US 201662352634 P | [2019/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017151786 | Date: | 08.09.2017 | Language: | EN | [2017/36] | Type: | A1 Application with search report | No.: | EP3423452 | Date: | 09.01.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.09.2017 takes the place of the publication of the European patent application. | [2019/02] | Search report(s) | International search report - published on: | US | 08.09.2017 | (Supplementary) European search report - dispatched on: | EP | 27.09.2019 | Classification | IPC: | C07D413/14, C07D401/12, A61K31/395, A61K31/4245, C07D403/12, C07D401/14, C07D405/12, C07D417/12, C07D249/06, C07D207/34, A61K31/353, A61K31/4184, A61K31/427, A61K31/4439, A61K31/422, A61K31/4725, C07D231/14, C07D413/12, C07D207/416, A61P35/00 | [2024/45] | CPC: |
C07D401/12 (EP,US);
A61K31/353 (EP,US);
A61K31/4184 (EP,US);
A61K31/422 (EP,US);
A61K31/4245 (EP,US);
A61K31/427 (EP,US);
A61K31/4439 (EP,US);
A61K31/4725 (EP,US);
A61K31/497 (EP,US);
A61K31/5377 (EP,US);
A61K31/541 (EP,US);
A61P1/16 (EP,US);
A61P3/10 (EP,US);
A61P35/00 (EP,US);
C07D207/34 (EP,US);
C07D207/416 (EP,US);
C07D231/14 (EP,US);
C07D249/06 (EP,US);
C07D401/14 (EP,US);
C07D403/12 (EP,US);
C07D405/12 (EP,US);
C07D413/12 (EP,US);
C07D413/14 (EP,US);
C07D417/12 (EP,US);
C07D417/14 (EP,US)
(-)
|
| Former IPC [2019/44] | C07D413/14, C07D401/12, A61K31/395, A61K31/4245, C07D403/12, C07D401/14, C07D405/12, C07D417/12, C07D249/06, C07D207/34 | ||
| Former IPC [2019/02] | C07D413/14, C07D401/12, A61K31/395, A61K31/4245 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/02] | Title | German: | WNT-SIGNALPFADINHIBITOREN ZUR BEHANDLUNGEN VON KRANKHEITEN | [2019/02] | English: | WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE | [2019/02] | French: | INHIBITEURS DE LA VOIE DE SIGNALISATION WNT POUR LE TRAITEMENT DE MALADIES | [2019/02] | Entry into regional phase | 28.09.2018 | National basic fee paid | 28.09.2018 | Search fee paid | 28.09.2018 | Designation fee(s) paid | 28.09.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 28.09.2018 | Examination requested [2019/02] | 29.04.2020 | Amendment by applicant (claims and/or description) | 01.07.2020 | Despatch of a communication from the examining division (Time limit: M04) | 06.11.2020 | Reply to a communication from the examining division | 09.02.2021 | Despatch of a communication from the examining division (Time limit: M04) | 18.06.2021 | Reply to a communication from the examining division | 30.09.2021 | Despatch of a communication from the examining division (Time limit: M04) | 17.12.2021 | Reply to a communication from the examining division | 09.06.2022 | Despatch of a communication from the examining division (Time limit: M06) | 14.12.2022 | Reply to a communication from the examining division | 15.03.2023 | Despatch of a communication from the examining division (Time limit: M04) | 24.07.2023 | Reply to a communication from the examining division | 16.10.2024 | Communication of intention to grant the patent | Fees paid | Renewal fee | 27.03.2019 | Renewal fee patent year 03 | 27.03.2020 | Renewal fee patent year 04 | 29.03.2021 | Renewal fee patent year 05 | 28.03.2022 | Renewal fee patent year 06 | 27.03.2023 | Renewal fee patent year 07 | 27.03.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2005086902 (SCION PHARMACEUTICALS INC [US], et al); | [X]WO2005086836 (SCION PHARMACEUTICALS INC [US], et al); | US2008234270 [ ] (CANNE BANNEN LYNNE [US], et al); | [X]US2011065725 (GARZYA VINCENZO [GB], et al); | [X]EP2423208 (LEAD DISCOVERY CENTER GMBH [DE], et al); | [XAI]CN103664876 (SOUTHEAST PHARMACEUTICALS CO LTD); | [X]EP2842938 (KOREA RES INST CHEM TECH [KR], et al); | [XP]WO2016166250 (QURIENT CO LTD [KR], et al); | [XP]WO2016170009 (ALMIRALL SA [ES]); | International search | [A]WO02068417 (NPS PHARMA INC [US], et al); | [X]US2011065725 (GARZYA VINCENZO [GB], et al); | [Y]US2013079329 (HOOD JOHN [US], et al); | [Y]US2014031374 (HOLSWORTH DANIEL [US], et al); | by applicant | CN104119317 |